LOOMIS SAYLES & CO L P - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
LOOMIS SAYLES & CO L P ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$617,946
-3.0%
6,066,617
-3.9%
1.06%
+3.4%
Q2 2023$637,248
+4.8%
6,315,010
-4.4%
1.03%
-2.7%
Q1 2023$607,858
-38.8%
6,607,149
-39.6%
1.06%
-46.9%
Q4 2022$993,021
-99.9%
10,945,998
-26.7%
1.99%
-13.5%
Q3 2022$1,134,811,000
-13.3%
14,929,752
-3.6%
2.30%
-5.4%
Q2 2022$1,308,966,000
-13.8%
15,485,220
-10.5%
2.43%
+19.7%
Q1 2022$1,518,706,000
-3.0%
17,307,187
-3.3%
2.03%
+7.2%
Q4 2021$1,565,150,000
+1.1%
17,893,566
-5.5%
1.89%
-0.6%
Q3 2021$1,548,868,000
-10.7%
18,939,445
-0.4%
1.90%
-9.5%
Q2 2021$1,735,348,000
+2.7%
19,019,589
-3.8%
2.10%
-3.9%
Q1 2021$1,689,835,000
-11.0%
19,768,777
-1.7%
2.19%
-12.9%
Q4 2020$1,899,717,000
+107.9%
20,117,729
+91.5%
2.51%
+88.8%
Q3 2020$913,580,000
-0.8%
10,505,750
-0.4%
1.33%
-10.0%
Q2 2020$920,923,000
+7.3%
10,544,119
+1.3%
1.48%
-16.4%
Q1 2020$858,119,000
-11.7%
10,407,756
+1.4%
1.77%
+7.0%
Q4 2019$972,005,000
+57.5%
10,265,132
+44.5%
1.65%
+39.1%
Q3 2019$617,235,000
-3.8%
7,102,815
+1.1%
1.19%
-0.8%
Q2 2019$641,739,000
-4.8%
7,028,136
+0.2%
1.20%
-9.5%
Q1 2019$674,070,000
+12.8%
7,011,335
+0.7%
1.32%
-6.1%
Q4 2018$597,594,000
-5.6%
6,964,149
-5.2%
1.41%
+13.7%
Q3 2018$632,925,000
+16.2%
7,345,919
+1.9%
1.24%
+12.6%
Q2 2018$544,620,000
-13.7%
7,209,699
-7.6%
1.10%
-17.7%
Q1 2018$630,799,000
+8.7%
7,802,086
+12.8%
1.34%
+10.8%
Q4 2017$580,574,000
-0.6%
6,914,888
+1.7%
1.21%
-5.1%
Q3 2017$583,789,000
+5.5%
6,800,107
+2.5%
1.27%
-2.3%
Q2 2017$553,541,000
+19.4%
6,631,613
+6.3%
1.30%
+12.8%
Q1 2017$463,537,000
+2.7%
6,241,239
+0.7%
1.16%
+4.1%
Q4 2016$451,570,000
-2.2%
6,199,477
+6.0%
1.11%
-5.2%
Q3 2016$461,951,000
-0.0%
5,850,438
+4.4%
1.17%
-6.8%
Q2 2016$462,156,000
+21.7%
5,601,211
+6.8%
1.26%
+16.4%
Q1 2016$379,800,000
-8.7%
5,242,948
+8.5%
1.08%
-7.9%
Q4 2015$415,915,000
-1.6%
4,833,976
+5.1%
1.17%
-6.4%
Q3 2015$422,840,000
+0.5%
4,600,090
+7.6%
1.25%
+9.0%
Q2 2015$420,617,000
+18.0%
4,277,164
+18.4%
1.15%
+16.3%
Q1 2015$356,337,000
+9.9%
3,613,603
+3.3%
0.99%
+9.9%
Q4 2014$324,164,000
+0.4%
3,498,428
+2.0%
0.90%
-5.0%
Q3 2014$322,857,000
+16.4%
3,429,908
+12.0%
0.95%
+20.2%
Q2 2014$277,260,000
+13.4%
3,062,631
+6.5%
0.79%
+13.6%
Q1 2014$244,543,000
+49.6%
2,876,296
+41.4%
0.69%
+41.1%
Q4 2013$163,473,000
+5.9%
2,033,745
+1.0%
0.49%
-1.8%
Q3 2013$154,425,000
+152.6%
2,013,099
+132.9%
0.50%
+129.4%
Q2 2013$61,132,000864,5420.22%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders